Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e68996
Publisher
Public Library of Science (PLoS)
Online
2013-07-19
DOI
10.1371/journal.pone.0068996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Genentech's Alzheimer's antibody trial to study disease prevention
- (2012) Ken Garber NATURE BIOTECHNOLOGY
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
- (2012) Maria Björkqvist et al. PLoS One
- Antigen-Bound and Free β-Amyloid Autoantibodies in Serum of Healthy Adults
- (2012) Madalina Maftei et al. PLoS One
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects
- (2011) Andrea C Klaver et al. Journal of Neuroinflammation
- Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
- (2011) R. Dodel et al. JOURNAL OF NEUROSCIENCE
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Immunotherapy for Alzheimer’s disease
- (2010) D. Morgan JOURNAL OF INTERNAL MEDICINE
- Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
- (2010) Johanna Magga et al. Journal of Neuroinflammation
- Plasma A 42 and A 40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
- (2010) T. T. Seppala et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study
- (2009) Katarzyna A. Gustaw-Rothenberg et al. EXPERIMENTAL GERONTOLOGY
- Amyloid β and APP as biomarkers for Alzheimer’s disease
- (2009) Henrik Zetterberg et al. EXPERIMENTAL GERONTOLOGY
- Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men
- (2008) Johan Sundelöf et al. ARCHIVES OF NEUROLOGY
- Plasma antibodies to Aβ40 and Aβ42 in patients with Alzheimer's disease and normal controls
- (2008) Wuhua Xu et al. BRAIN RESEARCH
- Antigenantibody dissociation in Alzheimer disease: a novel approach to diagnosis
- (2008) Katarzyna A. Gustaw et al. JOURNAL OF NEUROCHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Peripheral and central biodistribution of 111In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease
- (2008) Michael Bacher et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started